Is RGEN a good stock to buy? We came across a bullish thesis on Repligen Corporation on R. Dennis’s Substack by OppCost. In ...

Repligen Corporation (NASDAQ:RGEN) defied analyst predictions to release its third-quarter results, which were ahead of market expectations. The company beat both earnings and revenue forecasts, with ...

Biolife Solutions Inc. has attracted takeover interest from parties including diagnostics company Repligen Corp., according ...

Brown Capital Management, an investment management company, released its first quarter 2026 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q1 CY2026 results topping the market’s revenue ...

View Repligen Corporation RGEN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Repligen Corporation has acquired 908 Devices' desktop portfolio, which includes four analytical devices for bioprocessing applications, for $70 million in cash. This acquisition enhances Repligen's ...

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in ...

On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. The ...

Brown Capital Management, an investment management company, released its first quarter 2026 investor letter for “The Brown ...